• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Anticoagulant Sodium Citrate 4% w/v Solution, USP

 

Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P.
Manufacturer: Haemonetics Corporation, Braintree, MA
Indication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures
Approval Date: 3/3/2000
Type of submission: New Drug Application

 

 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002